Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease

Dopamine replacement by levodopa (L-DOPA) is the most widely used therapy for Parkinson’s disease (PD), however patients often develop side effects, known as L-DOPA-induced dyskinesia (LID), that usually need therapeutic intervention. There are no suitable therapeutic options for LID, except for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordone, Melina P., Damianich, Ana, Bernardi, Alejandra, Eidelman, Tomas, Sanz-Blasco, Sara, Gershanik, Oscar S., Avale, M. Elena, Ferrario, Juan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2021
Materias:
Research Article: New Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281260/
https://www.ncbi.nlm.nih.gov/pubmed/34099487
http://dx.doi.org/10.1523/ENEURO.0559-20.2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281260/
https://www.ncbi.nlm.nih.gov/pubmed/34099487
http://dx.doi.org/10.1523/ENEURO.0559-20.2021

Ejemplares similares